A delegation from XtalPi Inc., led by Chairman Dr. Wen Shuhao and CEO Dr. Ma Jian, visited the Shenzhen headquarters of China Merchants Group for in-depth discussions with Chairman Miao Jianmin and President Shi Dai. Zhang Junli, Assistant to the President and Director of the General Office at China Merchants Group, also participated in the activities.
Miao Jianmin and Shi Dai warmly welcomed the XtalPi delegation, led by Dr. Wen Shuhao and Dr. Ma Jian, and provided an overview of the group’s advancements in its science and technology innovation sector. They emphasized that China Merchants Group is accelerating its “Third Entrepreneurship” initiative, aligning with President Xi Jinping’s directives on artificial intelligence development. The group is actively pursuing its “AI+” strategy, focusing on three key areas: digital intelligence technology, life sciences, and green technology, to better serve national development goals. They acknowledged XtalPi’s leadership as a pioneer in AI-driven drug and material discovery, highlighting its achievements in building intelligent, automated experimental platforms and establishing a data-driven paradigm for pharmaceutical research through high-throughput, precision experiments and iterative technological advancements. Miao and Shi expressed a strong interest in deepening collaboration in technological innovation to seize opportunities in the new wave of scientific and industrial transformation.
Dr. Wen Shuhao and Dr. Ma Jian praised China Merchants Group’s rich history and extensive industry presence, noting its strong market applications and industrial foundation for advancing AI and large-scale data model training. They highlighted XtalPi’s role as an innovative technology company that has successfully applied AI across multiple sectors, including healthcare, with a focused approach to “one meter wide, one hundred meters deep” in its pursuit of transforming scientific discoveries into practical outcomes. The visit aimed to explore strategic synergies, with XtalPi eager to leverage this opportunity to collaborate with China Merchants Group and its innovation arm, China Merchants Innovation, in areas such as accelerated drug discovery, new material development, and chemical automation. Both parties aim to combine their strengths to achieve mutual growth.
Following the meeting, Dr. Wen Shuhao and Dr. Ma Jian delivered a presentation on XtalPi’s journey since its founding, focusing on its core strategy, “AI for Science,” and fielded questions from attendees. The sharing session was hosted by Deng Weidong, President of China Merchants Innovation. Key representatives from China Merchants Group, its affiliated units, and XtalPi also attended the event.A delegation from XtalPi Inc., led by Chairman Dr. Wen Shuhao and CEO Dr. Ma Jian, visited the Shenzhen headquarters of China Merchants Group for in-depth discussions with Chairman Miao Jianmin and President Shi Dai. Zhang Junli, Assistant to the President and Director of the General Office at China Merchants Group, also participated in the activities.
Miao Jianmin and Shi Dai warmly welcomed the XtalPi delegation, led by Dr. Wen Shuhao and Dr. Ma Jian, and provided an overview of the group’s advancements in its science and technology innovation sector. They emphasized that China Merchants Group is accelerating its “Third Entrepreneurship” initiative, aligning with President Xi Jinping’s directives on artificial intelligence development. The group is actively pursuing its “AI+” strategy, focusing on three key areas: digital intelligence technology, life sciences, and green technology, to better serve national development goals. They acknowledged XtalPi’s leadership as a pioneer in AI-driven drug and material discovery, highlighting its achievements in building intelligent, automated experimental platforms and establishing a data-driven paradigm for pharmaceutical research through high-throughput, precision experiments and iterative technological advancements. Miao and Shi expressed a strong interest in deepening collaboration in technological innovation to seize opportunities in the new wave of scientific and industrial transformation.
Dr. Wen Shuhao and Dr. Ma Jian praised China Merchants Group’s rich history and extensive industry presence, noting its strong market applications and industrial foundation for advancing AI and large-scale data model training. They highlighted XtalPi’s role as an innovative technology company that has successfully applied AI across multiple sectors, including healthcare, with a focused approach to “one meter wide, one hundred meters deep” in its pursuit of transforming scientific discoveries into practical outcomes. The visit aimed to explore strategic synergies, with XtalPi eager to leverage this opportunity to collaborate with China Merchants Group and its innovation arm, China Merchants Innovation, in areas such as accelerated drug discovery, new material development, and chemical automation. Both parties aim to combine their strengths to achieve mutual growth.
Following the meeting, Dr. Wen Shuhao and Dr. Ma Jian delivered a presentation on XtalPi’s journey since its founding, focusing on its core strategy, “AI for Science,” and fielded questions from attendees. The sharing session was hosted by Deng Weidong, President of China Merchants Innovation. Key representatives from China Merchants Group, its affiliated units, and XtalPi also attended the event.
